Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, et al. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol [Internet]. 2020 [cited 2023 Jan 22];11(2):55. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7141161/.

Hang TVP, Spiritos Z, Gamboa AM, Chen Z, Force S, Patel V, et al. Epidemiology of early esophageal adenocarcinoma. Clin Endosc [Internet]. 2022 [cited 2023 Jan 22];55(3):372–80. Available from: http://www.e-ce.org/journal/view.php?number=7617

Corona E, Yang L, Esrailian E, Ghassemi KA, Conklin JL, May FP. Trends in esophageal cancer mortality and stage at diagnosis by race and ethnicity in the United States. Cancer Causes Control. 2021;32(8):883–94. https://doi.org/10.1007/s10552-021-01443-z.

Article  PubMed  PubMed Central  Google Scholar 

Samarasam I. Esophageal cancer in India: current status and future perspectives. International Journal of Advanced Medical and Health Research [Internet]. 2017 [cited 2023 Jan 31];4(1):5. Available from: https://www.ijamhrjournal.org/article.asp?issn=2349-4220;year=2017;volume=4;issue=1;spage=5;epage=10;aulast=Samarasam

Khan F, Dana R, Kumar P. Esophageal cancer in North West India: a tertiary care center experience of 5 year. Asian Pacific Journal of Cancer Care [Internet]. 2021 [cited 2023 Jan 31];6(3):285–8. Available from: http://waocp.com/journal/index.php/apjcc/article/view/679

National Comprehensive Cancer Network. Esophageal & esophagogastric junction cancers (Version 1.2023) [Internet]. [cited 2023 Mar 6]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf

Puli SR, Reddy JBK, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol [Internet]. 2008 [cited 2023 Mar 15];14(10):1479–90. Available from: https://pubmed.ncbi.nlm.nih.gov/18330935/

Zhang Y, He S, Dou L, Liu Y, Ke Y, Yu X, et al. Esophageal cancer N staging study with endoscopic ultrasonography. Oncol Lett [Internet]. 2019 [cited 2023 Jan 31];17(1):863–70. Available from: http://www.spandidos-publications.com/10.3892/ol.2018.9716/abstract

Zeybek A, Erdoǧan A, Gülkesen KH, Ergin M, Sarper A, Dertsiz L, et al. Significance of tumor length as prognostic factor for esophageal cancer. Int Surg [Internet]. 2013 [cited 2023 Jan 31];98(3):234. Available from: https://pubmed.ncbi.nlm.nih.gov/23971777/.

Luu C, Amaral M, Klapman J, Harris C, Almhanna K, Hoffe S, et al. Endoscopic ultrasound staging for early esophageal cancer: are we denying patients neoadjuvant chemo-radiation? World J Gastroenterol [Internet]. 2017 [cited 2023 Feb 2];23(46):8193. Available from: https://pubmed.ncbi.nlm.nih.gov/29290655/.

Samson P, Puri V, Robinson C, Lockhart C, Carpenter D, Broderick S, et al. Clinical T2N0 esophageal cancer: identifying pretreatment characteristics associated with pathologic upstaging and the potential role for induction therapy. Ann Thorac Surg [Internet]. 2016 [cited 2023 Feb 2];101(6):2102–11. Available from: https://pubmed.ncbi.nlm.nih.gov/27083246/

Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27(30):5062–7.

Article  PubMed  Google Scholar 

Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol [Internet]. 2015 [cited 2023 Mar 5];16(9):1090–8. Available from: http://www.thelancet.com/article/S1470204515000406/fulltext

Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, et al. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg [Internet]. 2021 [cited 2023 Mar 5];156(8):721. Available from: https://pubmed.ncbi.nlm.nih.gov/34160577/.

Kato K, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, et al. A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. 2022;40(4_suppl):238–238. https://doi.org/10.1200/JCO2022404_suppl238.

Cerfolio RJ, Bryant AS. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg [Internet]. 2006 [cited 2023 Mar 17];82(2):391–5. Available from: https://pubmed.ncbi.nlm.nih.gov/16863735/

Li J, Qiu R, Hu Y, Wang Y, Qi Z, He M, et al. Postoperative adjuvant therapy for patients with pN+ esophageal squamous cell carcinoma. 2021 https://doi.org/10.1155/2021/8571438

Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol [Internet]. 2003 [cited 2023 Sep 13];21(24):4592–6. Available from: https://pubmed.ncbi.nlm.nih.gov/14673047/

Noronha V, Sekar A, Rajendra A, Mokal S, Patil V, Menon N, et al. Epidemiological trend of esophageal cancer at a tertiary cancer center in Mumbai, India, over the past 15 years. Journal of Gastrointestinal Cancer 2022 [Internet]. 2022 [cited 2022 Nov 29];1–10. Available from: https://link.springer.com/article/https://doi.org/10.1007/s12029-022-00887-z

de Nucci G, Petrone MC, Imperatore N, Asti E, Rossi G, Manes G, et al. Staging esophageal cancer: low EUS accuracy in t2n0 patients. Endosc Int Open. 2021;9(3):E313.

Article  PubMed  PubMed Central  Google Scholar 

Atay SM, Correa A, Hofstetter WL, Swisher SG, Ajani J, Altorki NK, et al. Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus. J Thorac Cardiovasc Surg [Internet]. 2019 [cited 2023 Feb 2];157(3):1264–1272.e6. Available from: https://pubmed.ncbi.nlm.nih.gov/30558879/

Wang M, Zhu Y, Li Z, Su P, Gao W, Huang C, et al. Impact of endoscopic ultrasonography on the accuracy of T staging in esophageal cancer and factors associated with its accuracy: a retrospective study. Medicine (United States) [Internet]. 2022 [cited 2023 Mar 17];101(8):E28603. Available from: https://journals.lww.com/md-journal/Fulltext/2022/02250/Impact_of_endoscopic_ultrasonography_on_the.4.aspx

Shin S, Kim HK wan, Choi YS oo, Kim K, Shim YM og. Clinical stage T1-T2N0M0 oesophageal cancer: accuracy of clinical staging and predictive factors for lymph node metastasis. Eur J Cardiothorac Surg [Internet]. 2014 [cited 2023 Mar 15];46(2):274–9. Available from: https://pubmed.ncbi.nlm.nih.gov/24634481/

Al-Kaabi A, van der Post RS, Huising J, Rosman C, Nagtegaal ID, Siersema PD. Predicting lymph node metastases with endoscopic resection in cT2N0M0 oesophageal cancer: a systematic review and meta-analysis. United European Gastroenterol J. 2020;8(1):35–43. https://doi.org/10.1177/2050640619879007.

Article  PubMed  Google Scholar 

Pouw RE, Heldoorn N, Herrero LA, Ten Kate FJW, Visser M, Busch OR, et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc [Internet]. 2011 [cited 2023 Mar 17];73(4):662–8. Available from: https://pubmed.ncbi.nlm.nih.gov/21272876/

Haisley KR, Hart CM, Kaempf AJ, Dash NR, Dolan JP, Hunter JG. Specific tumor characteristics predict upstaging in early-stage esophageal cancer. Ann Surg Oncol [Internet]. 2019 [cited 2023 Mar 15];26(2):514–22. Available from: https://pubmed.ncbi.nlm.nih.gov/30377918/

Ma MQ, Yu ZT, Tang P, Jiang HJ, Zhao XJ, Zhang JG, et al. Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients. Int J Clin Exp Pathol [Internet]. 2015 [cited 2023 Jan 31];8(5):5008. Available from: https://pubmed.ncbi.nlm.nih.gov/26191194/.

Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, et al. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2009;138(4):831–6.

Article  PubMed  Google Scholar 

Mehta N, Sadaps M, Shah RS, Jang S, Vargo J, McNamara M, et al. Tumor size increases the risk for lymph node metastases in T1b esophageal adenocarcinoma. Annals of Esophagus [Internet]. 2019 [cited 2023 Mar 7];2(0). Available from: https://aoe.amegroups.com/article/view/5098/html

Wu Z, Yu B. Tumor size as a critical prognostic factor in T1-2 stage esophageal cancer. Gastroenterol Res Pract. 2020;2020:279694. https://doi.org/10.1155/2020/2796943.

Sci-Hub | Tumor size as a critical prognostic factor in T1–2 stage esophageal cancer. Gastroenterology Research and Practice, 2020. https://doi.org/10.1155/2020/2796943

Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, et al. Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer? Dis Esophagus [Internet]. 2019 [cited 2023 Mar 15];32(10):1–6. Available from: https://pubmed.ncbi.nlm.nih.gov/30888418/

Shimizu D, Yuasa N, Miyake H, Takeuchi E, Miyata K, Itoh S. Clinical significance of SUVmax on preoperative 18F-fluorodeoxyglucose positron emission tomography in patients who underwent R0-esophagectomy for esophageal cancer. Nagoya J Med Sci [Internet]. 2018 [cited 2023 Feb 2];80(3):401. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6125650/.

Rizk N, Downey RJ, Akhurst T, Gonen M, Bains MS, Larson S, et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg [Internet]. 2006 [cited 2023 Mar 17];81(3):1076–81. Available from: https://pubmed.ncbi.nlm.nih.gov/16488726/

Goense L, Visser E, Haj Mohammad N, Mook S, Verhoeven RHA, Meijer GJ, et al. Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: a population-based cohort study. Eur J Surg Oncol [Internet]. 2018 [cited 2023 Feb 2];44(5):620–5. Available from: https://pubmed.ncbi.nlm.nih.gov/29478739/

Semenkovich TR, Panni RZ, Hudson JL, Thomas T, Elmore LC, Chang SH, et al. Comparative effectiveness of upfront esophagectomy vs induction chemoradiation in clinical stage T2N0 esophageal cancer: a decision analysis. J Thorac Cardiovasc Surg [Internet]. 2018 [cited 2023 Mar 15];155(5):2221. Available from: https://pubmed.ncbi.nlm.nih.gov/29428700/.

Mota FC, Cecconello I, Takeda FR, Tustumi F, Sallum RAA, Bernardo WM. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options. Int J Surg [Internet]. 2018 [cited 2023 Mar 15];54(Pt A):176–81. Available from: https://pubmed.ncbi.nlm.nih.gov/29730075/

Speicher PJ, Ganapathi AM, Englum BR, Hartwig MG, Onaitis MW, D’Amico TA, et al. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. J Thorac Oncol [Internet]. 2014 [cited 2023 Mar 15];9(8):1195–201. Available from: https://pubmed.ncbi.nlm.nih.gov/25157773/

Rice TW, Mason DP, Murthy SC, Zuccaro G, Adelstein DJ, Rybicki LA, et al. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg [Internet]. 2007 [cited 2023 Mar 15];133(2). Available from: https://pubmed.ncbi.nlm.nih.gov/17258554/

Mariette C, Dahan L, Mornex F, Maillard E, Thomas PA, Meunier B, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol [Internet]. 2014 [cited 2024 Aug 14];32(23):2416–22. Available from: https://pubmed.ncbi.nlm.nih.gov/24982463/